Be part of the knowledge.™

Ophthalmology

47

LikeLikedUnlike

31-45 of 70

Real-World Adaptation of Trial Protocols
MinuteCE®
Real-World Adaptation of Trial Protocols
- Roger A. Goldberg, MD, MBA
  Peer
- Ehsan Rahimy, MD
  Peer
1.00 program credits
Predicting Durability: Where Are We Now?
MinuteCE®
Predicting Durability: Where Are We Now?
- Justis P. Ehlers, MD, FASRS
  Peer
- Jennifer, I. Lim, MD, FASRS, FARVO
  Peer
1.00 program credits
New Strategies for Individualizing Treatment in DME
CME/CE
New Strategies for Individualizing Treatment in DME
- Luis A. Gonzalez, MD, MPH
  Peer
- Jeremiah Brown Jr., MD, MS, FASRS
  Peer
0.25 credits
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
CME/CE
From Doctor-Speak to Patient-Speak: Bridging the Communication Gap
- Luis A. Gonzalez, MD, MPH
  Peer
- Jeremiah Brown Jr., MD, MS, FASRS
  Peer
0.25 credits
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
CME/CE Broadcast Replay
Eye on the Target: Navigating Ocular Challenges With ADC Cancer Therapies
- Kathleen N. Moore, MD, MS, FASCO
  Peer
- Aaron Samuel Gold, OD, FAAO
  Peer
- Carlo J. Pelino, OD, FAAO
  Peer
1.00 credits
Understanding Antibody-Drug Conjugates (ADCs)
CME/CE
Understanding Antibody-Drug Conjugates (ADCs)
- Aaron Samuel Gold, OD, FAAO
  Peer
- Carlo J. Pelino, OD, FAAO
  Peer
0.25 credits
advertisement
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
CME/CE
Antibody Drug Conjugates: Insights and Challenges in Oncology and Ophthalmology
- Aaron Samuel Gold, OD, FAAO
  Peer
- Timothy G. Murray, MD, MBA, FASRS
  Peer
0.25 credits
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
CME/CE
Antibody Drug Conjugates: Pretreatment Assessment and Ocular Toxicity Awareness
- Kathleen N. Moore, MD, MS, FASCO
  Peer
- Kamran M. Riaz, MD
  Peer
0.25 credits
Collaborative Care: Managing ADC-Related Ocular Toxicities
CME/CE
Collaborative Care: Managing ADC-Related Ocular Toxicities
- Kathleen N. Moore, MD, MS, FASCO
  Peer
- Carlo J. Pelino, OD, FAAO
  Peer
0.25 credits
KOL KNOCKOUT^TM OCULOPLASTICS EDITION 8 Cases of Tailored Treatment for Thyroid Eye Disease
CME/CE
KOL KNOCKOUT^TM OCULOPLASTICS EDITION 8 Cases of Tailored Treatment for Thyroid Eye Disease
- Andrew R. Harrison, MD
  Peer
- Kian Eftekhari, MD
  Peer
- Andrew G. Lee, MD
  Peer
- Wendy W. Lee, MD
  Peer
- Nicholas Robert Mahoney, MD
  Peer
- Amina Malik, MD
  Peer
- Prem S. Subramanian, MD, PhD
  Peer
- Jeremiah Tao, MD, FACS
  Peer
1.00 credits
MinuteCE®
What’s New in Glaucoma Therapy?
- Paul Petrakos, DO, MS
  Peer
- Justin Schweitzer, OD, FAAO
  Peer
- I. Paul Singh, MD
  Peer
- Sarah H. Van Tassel, MD
  Peer
1.00 credits 10 episodes
What’s New in Glaucoma Topical Therapies?
MinuteCE®
What’s New in Glaucoma Topical Therapies?
- Justin Schweitzer, OD, FAAO
  Peer
- Sarah H. Van Tassel, MD
  Peer
1.00 program credits
advertisement
Evolving Strategies for Sustained-Release Glaucoma Treatments
MinuteCE®
Evolving Strategies for Sustained-Release Glaucoma Treatments
- Sarah H. Van Tassel, MD
  Peer
- Justin Schweitzer, OD, FAAO
  Peer
1.00 program credits
New Solutions for Optimizing IOP Control: A Case-Based Approach
MinuteCE®
New Solutions for Optimizing IOP Control: A Case-Based Approach
- Sarah H. Van Tassel, MD
  Peer
- Justin Schweitzer, OD, FAAO
  Peer
1.00 program credits
What’s New in Subconjunctival MIBS
MinuteCE®
What’s New in Subconjunctival MIBS
- Paul Petrakos, DO, MS
  Peer
- I. Paul Singh, MD
  Peer
1.00 program credits

Program Chapters

Segment Chapters

Playlist:

Recommended